China Pharma Holdings, Inc.
CPHI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106644
No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding China Pharma Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 5 | −1 |
| Shares | 337.9K | 118.7K | −219.2K (−64.9%) |
| Value | $88.3K | $211.5K | +$123.2K (+139.6%) |
New holders (2)
Institutions that held China Pharma Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 8,213 | $14.7K | 0.00% |
| Danske Bank A/S | 1 | $2 | 0.00% |
Sold out (3)
Institutions that held China Pharma Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| XTX Topco Ltd | 83,790 | $22.0K |
| Renaissance Technologies LLC | 46,100 | $12.1K |
| Two Sigma Securities, LLC | 25,337 | $6.67K |